Log In
person
Recursion Pharmaceauticals Inc
RXRX
summarize
2 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Pre-Rev Pharma |
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
44.58M | 100.00% |
| Pre-Rev Pharma |
Term License AI-Enabled Life Science Drug Research Platform
These companies provide a term license artificial intelligence-enabled platform used to research pharmaceutical and biotech products.
|
Non-Attributed |
Non-Attributed
help
Why Zero? Explanation of what the heck's going on here.
|
| keyboard_arrow_down |
Pre-Rev Pharma
Pre-Revenue Pharmaceuticals
|
44.58M | 100.00% |
| keyboard_arrow_right |
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
||
| keyboard_arrow_down |
Pre-Rev Pharma
Term License AI-Enabled Life Science Drug Research Platform
|
Non-Attributed |
Non-Attributed
help
Why Zero? Explanation of what the heck's going on here.
|
| keyboard_arrow_right |
help
Why Zero? Explanation of what the heck's going on here.
These companies provide a term license artificial intelligence-enabled platform used to research pharmaceutical and biotech products.
|
||